Skip to main content
letter
. 2023 May 5;13(1):70. doi: 10.1038/s41408-023-00838-2

Fig. 2. Differentially expressed genes and survival analysis of two distinct sub-cohorts of patients with CEBPAmut AML.

Fig. 2

A Top ten DEGs identified as up- (red) or down- (blue) regulated were ranked by the the magnitude of expression value change. B Volcano plot showing DEGs according to the two distinct sub-cohorts clustered by unsupervised hierarchy. C Kaplan–Meier curves for the survival of LR (upper panel) and HR (lower panel) CEBPAmut AML patients according to treatment of allo-HSCT in CR1 or chemotherapy-only. D Kaplan–Meier curves for the OS of HR CEBPAmut AML patients within the BeatAML cohort according to treatment of allo-HSCT or chemotherapy-only.